Spots Global Cancer Trial Database for Testosterone & Tamoxifen Trial
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Testosterone & Tamoxifen Trial
Official Title: T&T Trial: Adding Testosterone to Tamoxifen in Male Breast Cancer Patients
Study ID: NCT05156606
Conditions
Interventions
Study Description
Brief Summary: This is a concise single arm, feasibility study, which will be executed in the University Medical Center Groningen, The Netherlands. Male patients with metastatic BC (n=6) are eligible for this study after at least 1 line of conventional endocrine therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
UMCG, Groningen, , Netherlands
Contact Details
Name: Geke A.P. Hospers, MD,PhD
Affiliation: UMCG
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
